GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells
Source abstract
Abstract
Osteoporosis-related bone fracture and falls have a severe impact on patients' daily lives. Osteoblasts are bone-building cells that play a vital role in bone formation and remodeling. Imbalanced osteoblast differentiation could lead to osteoporosis. GPR39 is an orphan G protein-coupled receptor that mediates metabolic pathways. In this study, we show that GPR39 is expressed in MC3T3-E1 cells. Osteoblast differentiation culture media induces GPR39, suggesting that GPR39 is a differentiation-responsive factor. Activation of GPR39 using its selective agonist TC-G 1008 induces alkaline phosphatase (ALP), osteocalcin (OCN), and type I collagen (Col-I) expression, and increases cellular ALP activity and calcium deposition, implying that GPR activation promotes cells toward osteoblast differentiation. Treatment with TC-G 1008 also increases Runx-2 expression and AMPK activation. However, the inhibition of AMPK by Compound C abolished TC-G 1008-mediated ALP, OCN, and Col-I induction, and reduces ALP activity and cellular calcium deposition as well as Runx-2 induction. These data indicate that TC-G 1008-mediated GPR39 activation involves AMPK-mediated Runx-2 induction. In summary, our study uncovers a new role of GPR39 activation in osteoblast differentiation, implying that GPR39 could be a promising therapeutic target for osteoporosis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Receptor Mechanisms and Signaling · Protein Kinase Regulation and GTPase Signaling · Metabolism, Diabetes, and Cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Medicine, Shandong University
Department of Orthopedics, Qilu Hospital, Shandong University
Department of Orthopedics, East Hospital of Shouguang People's Hospital
Department of Orthopedics, Shandong Tai'an Coal Mine Hospital
Department of Spine Surgery, Tengzhou Central People’s Hospital
College of Physics and Electronic Sciences, Shandong Normal University
Funding
China Postdoctoral Science Foundation
References (22)
Show source-provided references
1. 10.1517/14656566.2016.112485610.1517/14656566.2016.1124856 ↗
2. 10.1146/annurev-pathol-011110-13020310.1146/annurev-pathol-011110-130203 ↗
3. 10.1016/j.diff.2016.02.00510.1016/j.diff.2016.02.005 ↗
4. 10.1111/ecc.1274010.1111/ecc.12740 ↗
5. 10.1097/BCO.0b013e328263085110.1097/BCO.0b013e3282630851 ↗
6. 10.1016/S0140-6736(10)62349-510.1016/S0140-6736(10)62349-5 ↗
7. 10.1038/nrd.2017.17810.1038/nrd.2017.178 ↗
8. 10.3390/ijms1902043910.3390/ijms19020439 ↗
9. 10.1021/ml500240d10.1021/ml500240d ↗
10. 10.1016/j.bcp.2017.06.11510.1016/j.bcp.2017.06.115 ↗
11. 10.1186/1472-6793-11-1210.1186/1472-6793-11-12 ↗
12. 10.1097/01.wnr.0000175243.12966.f510.1097/01.wnr.0000175243.12966.f5 ↗
13. 10.1111/jnc.1376010.1111/jnc.13760 ↗
14. 10.1152/ajpendo.90677.200810.1152/ajpendo.90677.2008 ↗
15. 10.1016/j.jad.2016.05.00710.1016/j.jad.2016.05.007 ↗
16. 10.1083/jcb.96.1.19110.1083/jcb.96.1.191 ↗
17. 10.1100/tsw.2010.5810.1100/tsw.2010.58 ↗
18. 10.1016/j.niox.2018.03.00710.1016/j.niox.2018.03.007 ↗
19. 10.1161/CIRCRESAHA.108.18756710.1161/CIRCRESAHA.108.187567 ↗
20. 10.1016/j.bbrc.2010.12.09910.1016/j.bbrc.2010.12.099 ↗
21. 10.1096/fj.201700661RR10.1096/fj.201700661RR ↗
22. 10.1242/dev.03357110.1242/dev.033571 ↗